CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 101,437 enrolled
Drug / intervention
Asthma treatment with an asthma-related medication and at least one asthma controller medicationdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01346852
NCT01346852N/ACompleted

Predictive Ability of Therapeutic Risk Factors in Pediatric and Adult Asthma Patients

GlaxoSmithKline·observational·Posted May 3, 2011·Updated May 30, 2017

In Brief

An observational study evaluating Asthma treatment with an asthma-related medication and at least one asthma controller medication for Asthma. Completed, enrolled 101,437 participants.

Detailed Summary

The purpose of this study is to assess the predictive ability of three asthma risk markers: the ratio of controller medication to total asthma medication, an albuterol only marker, and an oral corticosteroid use marker, as well as to compare the precision of these tools between adult and pediatric patient populations. This retrospective longitudinal analysis will use 2 different databases: a large managed care database and a large fee for service Medicaid database.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAsthma
Countries--
Collaborators--

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedMay 3, 2011
Enrollment StartJul 1, 2009
Primary CompletionApr 1, 2010
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 15.2 years ago

Interventions

Asthma treatment with an asthma-related medication and at least one asthma controller medicationdrug

participants with an asthma diagnosis who also had at least one dispensing event of an asthma-related medication and had at least one asthma controller medication (inhaled corticosteroids containing inhalers, methylxanthines, leukotriene receptor antagonists, cromolyn sodium) or albuterol.